Accelerate Diagnostics, Inc Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Accelerate Diagnostics, Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.16M, a 36.4% decline year-over-year.
  • Accelerate Diagnostics, Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.78M, a 26.1% decline year-over-year.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2023 was $5.39M, a 49.3% decline from 2022.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 51.8% decline from 2021.
  • Accelerate Diagnostics, Inc annual Share-based Payment Arrangement, Expense for 2021 was $22M, a 33.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.39M -$5.24M -49.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $10.6M -$11.4M -51.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $22M +$5.58M +33.9% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-29
2020 $16.5M +$3.85M +30.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 $12.6M -$1.8M -12.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $14.4M +$489K +3.51% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-02
2017 $13.9M +$5.16M +58.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $8.78M +$387K +4.61% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $8.39M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.